[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100526579":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":45,"collaborators":19,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":55,"maxAge":19,"enrollmentInfo":56,"targetDuration":19,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":19,"overallStatus":33,"whyStopped":19,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"University Hospital, Clermont-Ferrand","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Rathus Assertiveness scale","EXPERIMENTAL","All participants",[13],"Diagnostic Test: Rathus Assertiveness scale",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DIAGNOSTIC_TEST","Questionnaire completion",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Isabelle JALENQUES","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":19,"email":29},"Lise Laclautre","CONTACT","334.73.754.963","promo_interne_drci@chu-clermontferrand.fr",[31],{"facility":32,"status":33,"city":34,"state":35,"zip":19,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"CHU Clermont-Ferrand","RECRUITING","Clermont-Ferrand","France","FR",{"type":38,"coordinates":39},"Point",[40,41],3.08682,45.77969,{"lat":41,"lon":40},[44],{"name":26,"role":27,"phone":19,"phoneExt":19,"email":19},{"type":46,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100526579","epidemiology-of-assertiveness-and-emotion-management-disorders-in-people-with-tourettes-syndrome-100526579",false,"NCT06136572","Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome","AFFIRMATICS","Inclusion Criteria:\n\n* Tourette syndrome\n* Participants aged 18 years or over\n\nExclusion Criteria:\n\n* Participants under legal protection\n* Inability to complete questionnaires alone","ALL","18 Years",{"count":57,"type":58},350,"ESTIMATED","INTERVENTIONAL",[61],"NA","The goal of this study is to evaluate the proportion of assertiveness difficulties in Tourette syndrome. Participants will complete several e-questionnaires (on assertiveness, Tourette severity, quality of life, self-esteem and comorbidities like depression, anxiety...).",[64],"Tourette Syndrome","2026-02-25",{"date":67,"type":68},"2026-02-27","ACTUAL",{"date":70,"type":68},"2024-05-06",{"date":72,"type":58},"2026-11-05",{"name":5,"class":6},1]